Abstract:Background: Myocardial infarction (MI) is one of the most serious cardiovascular diseases, characterized by a rapid and irreversible decline in myocardial function. Early detection of patients with MI and prolonging the optimal therapeutic window of acute myocardial infarction (AMI) are particularly important. This study aimed to identify the diagnostic biomarkers and novel therapeutic targets for acute myocardial infarction.Method: We generated the AMI mouse models by ligating the proximal left anterior descending coronary artery. Six time points-Sham, AMI 10-min, 1-h, 6-h, 24-h, and 72-h-were chosen to examine the molecular changes that occur during the AMI process. RNA-seq and DIA-MS were performed on the infarcted left ventricular tissues of AMI mice at each time point. Co-expression pattern genes were screened from myocardial infarction samples at different time points by time-series analysis. Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were used to examine these genes. Using the Interactive Gene/Protein Retrieval Tool (STRING) database, the protein-protein interaction network (PPI) was constructed and the hub genes were identified. In order to evaluate the diagnostic value of hub genes, a receiver operating characteristic (ROC) curve was constructed. An independent data set, GSE163772, confirmed the diagnostic value of hub genes further.Result: We obtained the expression profiles at different time points after the occurrence of heart failure through high-throughput sequencing, and found 167 genes with similar expression patterns through time series analysis. The immune response and immune-related pathways had the greatest enrichment of these genes. Among them, Itgb2 Syk, Tlr4, Tlr2, Itgax, and Lcp2 may play key roles as hub genes. Combined with the results of proteomic analysis, it was found that the expression of Coro1a in both omics increased with time. The results of external validation showed that TLR2, ITGAX, and LCP2 had good predictive ability for AMI diagnosis.Conclusion: Itgb2, Syk, Tlr4, Tlr2, Itgax, Lcp2 and Coro1a are considered to be the seven key genes significantly associated with AMI. Our results may provide potential targets for the prevention of adverse ventricular remodeling and the treatment of AMI.

Two Desired Epitopes of Ctni Benefit for Preparation of Standardized Monoclonal Antibodies.

Expression of cTnI Specific Antigen Sites and Antibodies Detection

[Development, Identification and Application of 33 Monoclonal Antibodies Against Cardiac Troponin T].

The Impact of Antibody Selection on the Detection of Cardiac Troponin I.

Preparation of monoclonal antibodies against troponin I and development of one-step sandwich ELISA

Antigen Design in Production of Anti-Human Cardiac Troponin Ⅰ Monoclonal Antibody

Preparation of anti-cardiac troponin I monoclonal antibodies and their characterization with surface plasmon resonance biosensor

In-Vitro Diagnostic Reagent Evaluation of Commercially Available Cardiac Troponin I Assay Kits Using H/D Exchange Mass Spectrometry for Antibody-Epitope Mapping

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Development of a novel ssDNA aptamer targeting cardiac troponin I and its clinical applications

Preparation and identification of transmembrane TNF-α(TM-TNF-α)specific monoclonal antibody

High Sensitive and Multiple Detection of Acute Myocardial Infarction Biomarkers Based on a Dual-Readout Immunochromatography Test Strip

Fouling-Free Electrochemical Strategy based on Vertically-aligned Peptide Layer for Cardiac Troponin I Sensitive Detection in Human Serum

Establishment and Identification of Hybridoma Cell Lines Secreting Anti-human Myocardial Troponin T Antibody

Determination of affinities and antigenic epitopes of bovine cardiac troponin I (cTnI) with monoclonal antibodies by surface plasmon resonance biosensor.

Aptamer-Based Fluorescent Assay for Sensitive Detection of Cardiac Troponin I

Identification of molecular signatures in acute myocardial infarction based on integrative analysis of proteomics and transcriptomics

Immunohistochemical analysis of cardiac troponin inhibitor in an experimental model of acute myocardial infarction experimental model and in human tissues.

The analytical performance assessment and clinical practice of three sensitive cardiac troponin Ⅰ assays

Characterization and potential application of monoclonal antibody specific to monomeric C-reactive protein

[Preparation and Characterization of Monoclonal Antibodies Against CMTM7].